XARELTO

NDC 50458-577 · Janssen Pharmaceuticals, Inc.

Generic namerivaroxaban

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)RIVAROXABAN

Strength2.5 mg/1

Pharmacologic classFactor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]

Marketing categoryNDA

Packages

50458-577-10 — 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-577-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK (50458-577-01)

50458-577-14 — 14 TABLET, FILM COATED in 1 BOTTLE (50458-577-14)

50458-577-18 — 180 TABLET, FILM COATED in 1 BOTTLE (50458-577-18)

50458-577-60 — 60 TABLET, FILM COATED in 1 BOTTLE (50458-577-60)

FDA lists these products with the same active ingredient.

46708-346 — RIVAROXABAN, 46708-347 — RIVAROXABAN, 46708-348 — RIVAROXABAN, 46708-683 — RIVAROXABAN, 50090-3625 — rivaroxaban, 50090-3639 — rivaroxaban, 50090-4468 — rivaroxaban, 50090-4469 — rivaroxaban, 50228-513 — Rivaroxaban, 50458-575 — rivaroxaban, 50458-578 — rivaroxaban, 50458-579 — rivaroxaban, 50458-580 — rivaroxaban, 51672-4228 — Rivaroxaban, 55154-1422 — rivaroxaban, 55154-1423 — rivaroxaban, 55154-1424 — rivaroxaban, 55488-0540 — rivaroxaban, 55488-0541 — rivaroxaban, 55488-0542 — rivaroxaban, +23 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.